Drug intelligence / Profile preview

4-methylcyclohexylamine

Development stage
Preclinical
Lead developer
HUN-REN Research Centre for Natural Sciences
Modality
Small Molecules
Administration
Intraperitoneal
01

Overview

4-MCHA (4-methylcyclohexylamine) is a small molecule inhibitor of spermidine synthase (SRM), an enzyme critical to the polyamine biosynthetic pathway. It functions by blocking the conversion of putrescine into spermidine. In neurological research, particularly concerning epilepsy, 4-MCHA is used to modulate astrocytic metabolism. By inhibiting spermidine synthesis, the compound promotes the shunting of putrescine toward the production of GABA within astrocytes. This increased GABA is subsequently released into the extracellular space via GAT-2/3 transporters, providing enhanced tonic inhibition to neurons. Experimental studies in animal models, such as the WAG/Rij rat model of absence epilepsy, have demonstrated that 4-MCHA can effectively prevent seizure generation, suggesting that targeting the astrocytic polyamine-GABA pathway may be a viable strategy for antiepileptic drug development.

Other names
trans-4-methylcyclohexylaminetrans4-methylcyclohexylaminetrans 4-methylcyclohexylamine4-methylcyclohexan-1-amine
02

Targets

SRM (Spermidine synthase)

Beyond the preview

Go deeper on 4-methylcyclohexylamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 4-methylcyclohexylamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call